Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Events symbols : PPRUY save search
iOnctura to Present at ASCO IOA-244 Showing Highly Promising Impact on Overall Survival for Patients With Metastatic and Refractory Uveal Melanoma
Published: 2022-05-27 (Crawled : 09:00) - biospace.com/
PPRUF | News | $364.27 1.63% 37.56% 0
|
Consumer Non-Durables
|
| O: 6.63%
H: 1.14%
C: -2.81%
PPRUY | News | $36.96 2.44% -0.11% 0
|
Manufacturing
|
| O: 3.61%
H: 1.25%
C: 1.14%
ioa-244 melanoma asco
InterVenn to Present New Clinical Data at ASCO 2022 on Using Glycoproteomics as Powerful Liquid Biopsy Tests for Early Detection of Cancer and Prediction of Checkpoint Inhibitor Treatment Benefit
Published: 2022-05-06 (Crawled : 19:00) - biospace.com/
PPRUF | News | $364.27 1.63% 37.56% 0
|
Consumer Non-Durables
|
| O: -0.99%
H: 2.35%
C: -1.24%
PPRUY | News | $36.96 2.44% -0.11% 0
|
Manufacturing
|
| O: -2.72%
H: 1.32%
C: -0.12%
treatment asco cancer
iOnctura to Share Clinical and Preclinical Data on IOA-244 and IOA-289 at ESMO-IO in December 2021
Published: 2021-11-23 (Crawled : 09:00) - biospace.com/
PPRUF | News | $364.27 1.63% 37.56% 0
|
Consumer Non-Durables
|
| O: -0.6%
H: 0.0%
C: -0.51%
PPRUY | News | $36.96 2.44% -0.11% 0
|
Manufacturing
|
| O: 0.03%
H: 0.49%
C: 0.49%
preclinical pre-clinical
Gainers vs Losers
| 74% | 26% |
Top 10 Gainers
MTTR | News M | $4.625 165.81% 5.5M
|
AGBA | $2.615 109.2% 14M
|
Finance
EDBL | News | $7.37 96.01% 650K
|
PALI | $7.64 54.97% 14M
|
Manufacturing
OPRT | News | $3.19 41.78% 3M
|
Finance
PEGY | $0.0629 37.34% 110M
|
Manufacturing
MLEC | $1.87 33.57% 1.6M
|
n/a
ATGL | $3.66 27.97% 150K
|
KULR | $0.5446 22.0% 6.8M
|
Manufacturing
MDIA 4 | $2.205 21.15% 150K
|
Consumer Services
Your saved searches
Save your searches and get alerts when important news are released.